PMV Pharmaceuticals, Inc.

NASDAQ:PMVP

1.74 (USD) • At close November 8, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Operating Activities:
Net Income -68.96-73.317-57.846-34.44-25.352-17.538
Depreciation & Amortization 1.2570.3150.3070.3180.3880.338
Deferred Income Tax -0.23500.550.1520.0620.319
Stock Based Compensation 12.37510.1955.341.9330.9081.079
Change In Working Capital 5.427-0.5684.123-0.8451.9210.637
Accounts Receivables 000000
Inventory 000000
Accounts Payables 0.235-0.3890.191-1.231.7990.267
Other Working Capital 5.192-0.1793.9320.3850.1220.37
Other Non Cash Items -5.521-0.3850.9550.1430.008-0.013
Operating Cash Flow -55.657-63.76-46.571-32.739-22.065-15.178
Investing Activities:
Investments In Property Plant And Equipment -0.962-7.984-1.349-0.148-0.109-0.452
Acquisitions Net 0.05-0.0072.740.148-0.0030
Purchases Of Investments -220.539-229.199-256.845-14.512-43.452-48.678
Sales Maturities Of Investments 170.956235.815114.6142.57146.79270.823
Other Investing Activites -0.050.007-2.74-0.1480.00322.145
Investing Cash Flow -50.545-1.368-143.58427.9113.23121.693
Financing Activities:
Debt Repayment 000000
Common Stock Issued 35.5770.9582.022292.97261.8050
Common Stock Repurchased 000000
Dividends Paid 000000
Other Financing Activities 0.4560.0010292.972-0.1680
Financing Cash Flow 35.5770.9582.022292.97261.8050
Other Information:
Effect Of Forex Changes On Cash 0.03400000
Net Change In Cash -70.591-64.17-188.133288.14442.9716.515
Cash At End Of Period 38.528109.119173.289361.42273.27830.307